Recently, Gambaryan et al. [27] reported that the effect of CXCR4 antagonist on hypoxia-induced pulmonary hypertension and vascular remodeling in mice was associated with a significantly decreased number of perivascular c-kit+ hematopoietic progenitor cells. This evidence concerns the gene CXCR4 and pulmonary hypertension.